Netherlands Foreign Investment Agency (NFIA) has shown interest in perusing pharma plyers from Gujrat to set up R&D facility in Netherlands, which constitutes a market of Rs 13,000 crore.
This step is a result of Reserve Bank of India’s release of its 2008-2009 outward FDI report. The report says that Netherlands was the second preferred FDI investment from India after Singapore.
The initiative from NFIA comes soon after Reserve Bank of India released its 2008-2009 outward FDI report, which says Netherlands was the second preferred FDI investment from India after Singapore. In the last financial year Netherlands received 17% of all cleared proposals in India.
Robert Schipper, executive director of NFIA, said: Companies that export to Europe obviously feel the need to be closer to their customers. Pharmaceutical companies, which look for possibilities to co-operate with research institutes in Europe, should keep in mind that Netherlands has excellent pharmacological research. we need Indian companies, especially companies from Gujarat, to help us develop new products on the basis of excellent research being done in Netherlands.